These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 20125087)

  • 1. Viral shape-shifting: norovirus evasion of the human immune system.
    Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
    Nat Rev Microbiol; 2010 Mar; 8(3):231-41. PubMed ID: 20125087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.
    Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
    Immunol Rev; 2008 Oct; 225():190-211. PubMed ID: 18837783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norovirus immunity and the great escape.
    Debbink K; Lindesmith LC; Donaldson EF; Baric RS
    PLoS Pathog; 2012; 8(10):e1002921. PubMed ID: 23093932
    [No Abstract]   [Full Text] [Related]  

  • 4. Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization.
    Kolawole AO; Li M; Xia C; Fischer AE; Giacobbi NS; Rippinger CM; Proescher JB; Wu SK; Bessling SL; Gamez M; Yu C; Zhang R; Mehoke TS; Pipas JM; Wolfe JT; Lin JS; Feldman AB; Smith TJ; Wobus CE
    J Virol; 2014 Apr; 88(8):4543-57. PubMed ID: 24501415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norovirus.
    Robilotti E; Deresinski S; Pinsky BA
    Clin Microbiol Rev; 2015 Jan; 28(1):134-64. PubMed ID: 25567225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the global burden of noroviruses and opportunities for prevention.
    Hall AJ; Glass RI; Parashar UD
    Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965
    [No Abstract]   [Full Text] [Related]  

  • 8. Norovirus mechanisms of immune antagonism.
    Roth AN; Karst SM
    Curr Opin Virol; 2016 Feb; 16():24-30. PubMed ID: 26673810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon responses to norovirus infections: current and future perspectives.
    Jahun AS; Goodfellow IG
    J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34698626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian resistance to human norovirus infections.
    Le Pendu J; Ruvoën-Clouet N; Kindberg E; Svensson L
    Semin Immunol; 2006 Dec; 18(6):375-86. PubMed ID: 16973373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noroviruses: epidemiology, immunity and prospects for prevention.
    Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ
    Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human norovirus transmission and evolution in a changing world.
    de Graaf M; van Beek J; Koopmans MP
    Nat Rev Microbiol; 2016 Jul; 14(7):421-33. PubMed ID: 27211790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.
    Chachu KA; LoBue AD; Strong DW; Baric RS; Virgin HW
    PLoS Pathog; 2008 Dec; 4(12):e1000236. PubMed ID: 19079577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norovirus Infection: Replication, Manipulation of Host, and Interaction with the Host Immune Response.
    Sarvestani ST; Cotton B; Fritzlar S; O'Donnell TB; Mackenzie JM
    J Interferon Cytokine Res; 2016 Apr; 36(4):215-25. PubMed ID: 27046239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus vaccines under development.
    Lucero Y; Vidal R; O'Ryan G M
    Vaccine; 2018 Aug; 36(36):5435-5441. PubMed ID: 28668568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.
    Nice TJ; Baldridge MT; McCune BT; Norman JM; Lazear HM; Artyomov M; Diamond MS; Virgin HW
    Science; 2015 Jan; 347(6219):269-73. PubMed ID: 25431489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in norovirus biology.
    Karst SM; Wobus CE; Goodfellow IG; Green KY; Virgin HW
    Cell Host Microbe; 2014 Jun; 15(6):668-80. PubMed ID: 24922570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation and Protective Capacity of Virus-Specific CD8
    Tomov VT; Palko O; Lau CW; Pattekar A; Sun Y; Tacheva R; Bengsch B; Manne S; Cosma GL; Eisenlohr LC; Nice TJ; Virgin HW; Wherry EJ
    Immunity; 2017 Oct; 47(4):723-738.e5. PubMed ID: 29031786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the relationship between norovirus diversity and immunity.
    Ford-Siltz LA; Tohma K; Parra GI
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33783322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.